Following the suspension of bilateral trade due to escalating tensions between India and Pakistan, the negative impact on Pakistan’s pharmaceutical sector has become increasingly evident.
According to media reports, approximately 30% of the raw materials used in local drug manufacturing are imported from India. With this supply chain now disrupted, the country is facing a severe shortage of essential medicines—most critically in the federal capital, Islamabad.
According to media reports, commonly used and vital medicines have become scarce in Islamabad.
Medical markets in the capital are reporting acute shortages of drugs used to treat fever, pain, stomach disorders, and respiratory issues.
Pharmacy owners have confirmed that some essential medicines are nearly unavailable in the market. These include Brufen, Flagyl, Pedialyte ORS, and Ventolin inhalers.
